Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

HistoWiz

Explore full profile

Provides automated histopathology for biomedical researchers

New York City, United StatesFounded 2012Biotech & Life Sciences
Valuation $100–500M Latest valuation · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for HistoWiz and the history behind them.

About HistoWiz

HistoWiz, Inc. provides automated histopathology services for researchers in the academic, biotechnology, and pharmaceutical sectors. The company was founded in 2012 by Ke Cheng, PhD, who now serves as a board member. The idea for the company stemmed from Dr. Cheng's own frustrations with the slow and inefficient workflow of traditional histopathology while working as a cancer researcher at Harvard and the Swiss Institute of Experimental Cancer Research. HistoWiz began operations in Brooklyn, NY, in January 2013.

Read full description

The company's business model centers on streamlining the histopathology process. Clients mail formalin-fixed tissue specimens to HistoWiz's labs. The company then handles tissue processing, embedding, sectioning, and staining, utilizing automation to ensure rapid turnaround times, often as fast as 48 hours. The results are digitized as high-resolution, whole-slide images and uploaded to a proprietary, cloud-based platform called PathologyMap™. This platform allows clients to instantly view, manage, analyze, and share their results from any computer or mobile device without needing to download large files. Revenue is generated through its service offerings, which can be paid for via credit card or purchase orders.

HistoWiz offers a comprehensive suite of services, including precision histology (H&E and special stains), immunostaining (IHC, ISH, and multiplex IF), and slide archiving with bulk whole-slide imaging. A key component of their offering is the PathologyMap™ platform, which not only provides access to digital slides but also includes features for collaboration and AI-driven analysis. This platform hosts what the company states is the world's largest preclinical pathology database, enabling data mining and discovery. Additionally, HistoWiz provides on-demand access to a network of over 100 board-certified pathologists for consultation, interpretation, and diagnosis for both GLP and non-GLP studies.

The company has raised a total of $33.5 million over four funding rounds. A significant milestone was the $32 million Series A round in October 2021, led by Vivo Capital, with participation from investors like venBio, Y Combinator, and Asahi Kasei. This funding was aimed at expanding services, building a flagship lab with advanced robotics, and growing the team. HistoWiz's current CEO is Linh Hoang, MD, PhD. Keywords: histopathology services, digital pathology, preclinical research, tissue processing, whole-slide imaging, PathologyMap, cancer research, drug discovery, automated histology, pathology consultation, immunostaining, slide scanning, laboratory information system, online pathology database, research tools, GLP histology, IHC staining, tissue archiving, biomarker analysis, telepathology, AI in pathology

Source: Dealroom company data

At a glance

Status
Operational
Founded
2012
Headquarters
New York City, United States
Employees
49
Open positions
11
Dealroom signal
65.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Drug Development, Biotech and Pharma, Hard Tech, YC W16, DT and LS, science-based
Business model
Manufacturing
Client focus
b2c

Latest news

Press, funding announcements and product moves mentioning HistoWiz.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Oct 2021 $32M $128M Vivo Capital · venBio Partners · Jon Oringer
SEEDEquity / VC Feb 2018 $2.8M $11M Undisclosed
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

HistoWiz website traffic

Latest recorded traffic for HistoWiz is 7.4K monthly website visits, down 38.3% over the last three months. HistoWiz's team declined 12.5% over the past year.

Latest monthly visits7.4K 3-month web change-38.3% 1-year team growth-12.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A3 investors entered at this stage

Other known investors3 additional known investors

  • Asahi Kasei Ventures
  • Downstate Biotechnology Incubator
  • MicroVentures
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States92.5%
🇨🇦 Canada5%
🇦🇪 United Arab Emirates2.5%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about HistoWiz on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See HistoWiz’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.